Studies have reported that the expression of exosome-lncRNA H19 in serum of bladder cancer patients is upregulated [16], and exosome-lncRNA PTENP1 in plasma is downregulated [40], both of which can serve as good tumour markers for bladder cancer diagnosis. The gene discussed is H19; the disease is urinary bladder carcinoma.